Comparison between Brooks Laboratories IPO and SRS IPO.
Brooks Laboratories IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SRS IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Brooks Laboratories IPO is up to ₹63.00 Cr whereas the issue size of the SRS IPO is up to ₹203.00 Cr. The final issue price of Brooks Laboratories IPO is ₹100.00 per share and of SRS IPO is ₹58.00 per share.
| Brooks Laboratories IPO | SRS IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹90.00 per share | ₹58.00 per share |
| Issue Price (Upper) | ₹100.00 per share | ₹65.00 per share |
| Issue Price (Final) | ₹100.00 per share | ₹58.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 60 shares | 100 shares |
| Fresh Issue Size | 63,00,000 shares | 3,50,00,004 shares |
| Fresh Issue Size (Amount) | up to ₹63.00 Cr | up to ₹203.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 63,00,000 shares | 3,50,00,004 shares |
| Issue Size Total (Amount) | up to ₹63.00 Cr | up to ₹203.00 Cr |
Brooks Laboratories IPO opens on Aug 16, 2011, while SRS IPO opens on Aug 23, 2011. The closing date of Brooks Laboratories IPO and SRS IPO is Aug 18, 2011, and Aug 26, 2011, respectively.
| Brooks Laboratories IPO | SRS IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 16, 2011 | Aug 23, 2011 |
| Issue Close | Aug 18, 2011 | Aug 26, 2011 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 05, 2011 | Sep 16, 2011 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Brooks Laboratories IPO P/E ratio is , as compared to SRS IPO P/E ratio of .
| Brooks Laboratories IPO | SRS IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.5 | 98.89 | ||||
| Promoter Shareholding (Post-Issue) | 60.77 | 74.04 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹161.86 Cr. | ₹807.89 Cr. | ||||
| ROE | ||||||
| ROCE | 27.3 | 13.6 | ||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 47.4 | 11.9 |
In the Brooks Laboratories IPO Retail Individual Investors (RII) are offered 22,05,000 shares while in SRS IPO retail investors are offered 22,05,000 shares. Qualified Institutional Buyers (QIB) are offered 31,50,000 shares in Brooks Laboratories IPO and 1,75,00,000 shares in SRS IPO.
| Brooks Laboratories IPO | SRS IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 31,50,000 shares | 1,75,00,000 shares |
| NII | 9,45,000 shares | 52,50,000 shares |
| RII | 22,05,000 shares | 1,22,50,000 shares |
| Employee | ||
| Others | ||
| Total | 63,00,000 shares | 3,50,00,000 shares |
Brooks Laboratories IPO subscribed 1.78x in total, whereas SRS IPO subscribed 1.25x.
| Brooks Laboratories IPO | SRS IPO | |
|---|---|---|
| QIB (times) | 0.00x | 0.75x |
| NII (times) | 3.13x | 5.11x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.73x | 0.32x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.78x | 1.25x |
